Antares Pharma, Inc. - stock earnings
Stock symbol ATRS is outdated, potentially delisted? Maybe it is available on other exchange?
ATRS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021Q4 | 32.7 million USD | 48.7 million USD |
| 2021Q3 | 5.4 million USD | 48.2 million USD |
| 2021Q2 | 4.4 million USD | 45.0 million USD |
| 2021Q1 | 3.8 million USD | 42.1 million USD |
| 2020Q4 | 51.4 million USD | 44.1 million USD |
| 2020Q3 | 5.0 million USD | 40.0 million USD |
ATRS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | 46.3 million USD | 184.0 million USD |
| 2020 | 56.2 million USD | 149.6 million USD |
| 2019 | -2.0 million USD | 123.9 million USD |
| 2018 | -6.5 million USD | 63.6 million USD |
| 2017 | -16.7 million USD | 54.5 million USD |
ATRS
Price: $5.59
52 week price:
Earnings Per Share: 0.18 USD
P/E Ratio: 14.95
Exchange: NCM
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 1.8 million
Ebitda: -4.3 millionMarket Capitalization: 950.5 million